Verus Financial Partners Inc. boosted its stake in Maximus, Inc. (NYSE:MMS – Free Report) by 6.7% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 3,387 shares of the health services provider’s stock after purchasing an additional 214 shares during the period. Verus Financial Partners Inc.’s holdings in Maximus were worth $244,000 at the end of the most recent reporting period.
A number of other large investors have also bought and sold shares of MMS. GAMMA Investing LLC grew its position in shares of Maximus by 67.1% in the 1st quarter. GAMMA Investing LLC now owns 732 shares of the health services provider’s stock worth $50,000 after buying an additional 294 shares during the last quarter. Blue Trust Inc. grew its position in shares of Maximus by 32.8% in the 1st quarter. Blue Trust Inc. now owns 1,228 shares of the health services provider’s stock worth $84,000 after buying an additional 303 shares during the last quarter. Universal Beteiligungs und Servicegesellschaft mbH bought a new stake in shares of Maximus in the 1st quarter worth approximately $2,115,000. Janney Montgomery Scott LLC grew its position in shares of Maximus by 70.5% in the 1st quarter. Janney Montgomery Scott LLC now owns 10,145 shares of the health services provider’s stock worth $692,000 after buying an additional 4,196 shares during the last quarter. Finally, Oppenheimer Asset Management Inc. grew its position in shares of Maximus by 24.0% in the 1st quarter. Oppenheimer Asset Management Inc. now owns 6,461 shares of the health services provider’s stock worth $441,000 after buying an additional 1,249 shares during the last quarter. 97.21% of the stock is owned by hedge funds and other institutional investors.
Analysts Set New Price Targets
Separately, Zacks Research upgraded Maximus from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, August 26th. One research analyst has rated the stock with a Strong Buy rating and one has given a Buy rating to the company’s stock. According to data from MarketBeat, Maximus presently has an average rating of “Strong Buy” and an average target price of $90.00.
Insider Activity at Maximus
In other news, insider Michelle F. Link sold 1,610 shares of the firm’s stock in a transaction that occurred on Wednesday, October 1st. The stock was sold at an average price of $90.86, for a total value of $146,284.60. Following the completion of the transaction, the insider owned 13,508 shares in the company, valued at $1,227,336.88. This trade represents a 10.65% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. 1.60% of the stock is currently owned by insiders.
Maximus Trading Up 0.5%
MMS opened at $91.29 on Friday. The stock has a market cap of $5.14 billion, a PE ratio of 16.81 and a beta of 0.57. The company has a quick ratio of 2.27, a current ratio of 2.27 and a debt-to-equity ratio of 0.91. The business has a 50 day moving average of $84.70 and a 200-day moving average of $75.18. Maximus, Inc. has a 52 week low of $63.77 and a 52 week high of $93.73.
Maximus (NYSE:MMS – Get Free Report) last released its earnings results on Thursday, August 7th. The health services provider reported $2.16 EPS for the quarter, beating analysts’ consensus estimates of $1.39 by $0.77. The company had revenue of $1.35 billion during the quarter, compared to analysts’ expectations of $1.29 billion. Maximus had a return on equity of 24.44% and a net margin of 5.83%.The firm’s revenue for the quarter was up 2.5% compared to the same quarter last year. During the same quarter last year, the business posted $1.74 EPS. Maximus has set its FY 2025 guidance at 7.350-7.550 EPS. Equities research analysts predict that Maximus, Inc. will post 6.15 earnings per share for the current fiscal year.
Maximus Dividend Announcement
The company also recently announced a quarterly dividend, which was paid on Sunday, August 31st. Stockholders of record on Friday, August 15th were paid a $0.30 dividend. This represents a $1.20 dividend on an annualized basis and a dividend yield of 1.3%. The ex-dividend date was Friday, August 15th. Maximus’s dividend payout ratio (DPR) is presently 22.10%.
Maximus Company Profile
Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.
Further Reading
- Five stocks we like better than Maximus
- What Makes a Stock a Good Dividend Stock?
- General Dynamics Hits New Highs: Why It Might Keep Climbing
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- Nike’s Turnaround: If the Shoe Fits, Buy It!
- Asset Allocation Strategies in Volatile Markets
- NVIDIA Breaks Out to New Highs: What Comes Next?
Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with MarketBeat.com's FREE daily email newsletter.